상세 보기
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
- Park, In Hae;
- Kim, Gun Min;
- Kim, Jee Hyun;
- Kim, Hanjo;
- Park, Kyong Hwa;
- ... Lee, Gyeong-Won;
- 외 9명
Citations
WEB OF SCIENCE
8- 제목
- Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
- 저자
- Park, In Hae; Kim, Gun Min; Kim, Jee Hyun; Kim, Hanjo; Park, Kyong Hwa; Park, Yeon Hee; Baek, Sun Kyung; Sim, Sung Hoon; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Ji Eun; Lim, Seungtaek; Jung, Kyung Hae; Im, Seock-Ah
- 발행일
- 2020-05-20
- 유형
- Meeting Abstract
- 권
- 38
- 호
- 15
- 언어
- ENG
- 출판사
- American Society of Clinical Oncology
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X